Cyclopropyltributylstannane
Product Information
Molecular Formula
C15H32Sn
Molecular Weight
331.11
Description
Cyclopropyltributylstannane is a drug precursor that facilitates the synthesis of diverse organic entities. Its inherent adaptability renders it an invaluable asset in the spheres of cancer, HIV/AIDS, and neurological disorder management. Cyclopropyltributylstannane's unique chemical properties facilitate research into therapeutic interventions.
Synonyms
tributyl(cyclopropyl)stannane; Stannane, tributylcyclopropyl-; Tributyl-cyclopropyl-stannane; cyclopropyltributyltin; tributylcyclopropyltin; tributylcyclopropylstannane; tri-n-butyl-cyclopropyltin; tributyl-cyclopropylstannane; tri-n-butyl(cyclopropyl) tin; Cyclopropyltributylstannane
IUPAC Name
tributyl(cyclopropyl)stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C1CC1
InChI
InChI=1S/3C4H9.C3H5.Sn/c3*1-3-4-21-2-3-1/h3*1,3-4H2,2H31H,2-3H2
InChI Key
RUCOUXAHBYBPHL-CIBCYVJYAC
Purity
95%
Safety Information
Hazards
H301-H312-H315-H319-H372-H410
Precautionary Statement
P273-P280-P301 + P310 + P330-P302 + P352 + P312-P305 + P351 + P338-P501
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
0
Rotatable Bond Count
10
Exact Mass
332.152604 g/mol
Monoisotopic Mass
332.152604 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
151
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021195781-A1 | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use | 2020-04-01 |
| WO-2021195782-A1 | Methods of using myt1 inhibitors | 2020-04-01 |
| WO-2021142333-A2 | Inhibitors of microbially induced amyloid | 2020-01-10 |
| WO-2020104822-A1 | Compounds | 2018-11-23 |
| AU-2019383721-A1 | Compounds | 2018-11-23 |
| BR-112021009566-A2 | compounds | 2018-11-23 |
| CA-3117916-A1 | Compounds | 2018-11-23 |
| CN-113056305-A | Compound (I) | 2018-11-23 |
| EP-3883650-A1 | Compounds | 2018-11-23 |
| KR-20210095647-A | compound | 2018-11-23 |
